share_log

SVB Leerink Downgrades Axcella Health to Market Perform, Lowers Price Target to $2

Benzinga Real-time News ·  Dec 16, 2022 06:27

SVB Leerink analyst Mike Kratky downgrades Axcella Health (NASDAQ:AXLA) from Outperform to Market Perform and lowers the price target from $6 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment